Loading…
Company to showcase innovations in reproductive health at industry event.
Femasys Inc. (Nasdaq: FEMY) announced its participation in the American Society for Reproductive Medicine (ASRM) 2025 Scientific Congress & Expo, scheduled for October 25-29, 2025. The event will provide an opportunity for Femasys to present its latest advancements in minimally invasive gynecological solutions.
The ASRM Congress is a premier gathering for professionals in reproductive medicine, offering a platform for companies to display their cutting-edge technologies and engage with key opinion leaders in the field.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.